A new study has found that eating within three hours of bedtime at least four days a week could increase chances for developing colorectal cancer. This development was highlighted in an interview by ...

Results from the study showed that the cell-free DNA blood-based test had a sensitivity of 83.1% for CRC and a specificity of ...

WASHINGTON -- A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified sensitivity and ...

But a new study has found a link between colorectal cancer and when you eat. ”We wanted to see if the timing affects us at ...

Guardant Health’s blood test designed to help screen the population for hidden cases of colorectal cancer may have taken a ...

CPAs are the result of gene mutations leading to the development of two-layer nodules that have tumor-inducing and ...

Guardant Health (GH) stock fell after FDA reviewers expressed concerns about its Shield blood test for colorectal cancer ...

The PressureSafe device reduced the incidence of pressure injuries by 50% by detecting these pressure injuries to the skin ...

The U.S. FDA’s May 23 advisory hearing for the Shield test for colorectal cancer by Guardant Health Inc., included the ...

Guardant (GH) stock is on hold for trading as FDA advisors are set to review the company's marketing application for its ...

The favorable panel vote does not by any means imply this test will become an overnight success,” wrote William Blair analyst Andrew Brackmann.

Leerink Partners analyst Puneet Souda has maintained their bullish stance on GH stock, giving a Buy rating on May 22. Puneet Souda’s ...